Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)

Yifeng Pharmacy Chain Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	23,268	23,295	22,078	19,382	14,807	12,813
Other Revenue	753.75	767.13	510.66	504.62	519	331.15
Revenue	24,022	24,062	22,588	19,886	15,326	13,145
Revenue Growth (YoY)	1.60%	6.53%	13.59%	29.75%	16.60%	27.91%
Cost of Revenue	14,426	14,492	14,030	12,082	9,184	8,183
Gross Profit	9,595	9,570	8,558	7,805	6,143	4,961
Selling, General & Admin	7,195	7,262	6,450	5,782	4,717	3,705
Research & Development	32.06	33.94	33.55	25.31	15.64	8.31
Other Operating Expenses	51.7	52.63	57.59	59.1	28.18	49.95
Operating Expenses	7,276	7,347	6,546	5,877	4,765	3,770
Operating Income	2,319	2,224	2,012	1,928	1,377	1,191
Interest Expense	-219.67	-221.37	-160.53	-165.21	-168.99	-186.08
Interest & Investment Income	191.75	180.78	135.66	80.08	98.51	87.92
Other Non Operating Income (Expenses)	-20.62	-25.18	-18.94	-12.81	-10.03	-13.94
EBT Excluding Unusual Items	2,270	2,158	1,969	1,830	1,297	1,079
Impairment of Goodwill	-18.83	-18.83	-	-	-	-
Gain (Loss) on Sale of Assets	68.94	49.94	41.82	23.17	6.85	0.32
Asset Writedown	-3.84	-3.84	-12.73	-10.33	-1.43	-1.58
Other Unusual Items	-1.94	-2.66	39.87	34.99	35.49	49.39
Pretax Income	2,315	2,182	2,038	1,877	1,338	1,127
Income Tax Expense	576.04	529.67	456.66	454.06	347.16	287.92
Earnings From Continuing Operations	1,739	1,653	1,581	1,423	990.75	839.44
Minority Interest in Earnings	-127.6	-124.21	-168.95	-161.58	-102.86	-95.92
Net Income	1,611	1,529	1,412	1,262	887.88	743.52
Net Income to Common	1,611	1,529	1,412	1,262	887.88	743.52
Net Income Growth	7.07%	8.26%	11.90%	42.12%	19.42%	36.74%
Shares Outstanding (Basic)	1,212	1,213	1,207	1,202	1,193	1,157
Shares Outstanding (Diluted)	1,248	1,233	1,207	1,211	1,203	1,157
Shares Change (YoY)	3.73%	2.15%	-0.37%	0.70%	4.01%	0.31%
EPS (Basic)	1.33	1.26	1.17	1.05	0.74	0.64
EPS (Diluted)	1.29	1.24	1.17	1.04	0.74	0.64
EPS Growth	3.22%	5.98%	12.32%	41.13%	14.81%	36.32%
Free Cash Flow	3,433	3,539	3,884	3,333	1,322	1,747
Free Cash Flow Per Share	2.75	2.87	3.22	2.75	1.10	1.51
Dividend Per Share	0.700	0.650	0.417	0.238	0.179	0.137
Dividend Growth	5.00%	55.99%	75.01%	33.31%	29.98%	-
Gross Margin	39.94%	39.77%	37.89%	39.25%	40.08%	37.74%
Operating Margin	9.65%	9.24%	8.91%	9.69%	8.99%	9.06%
Profit Margin	6.71%	6.35%	6.25%	6.35%	5.79%	5.66%
Free Cash Flow Margin	14.29%	14.71%	17.19%	16.76%	8.63%	13.29%
EBITDA	2,574	2,473	2,231	2,115	1,521	1,303
EBITDA Margin	10.71%	10.28%	9.88%	10.63%	9.93%	9.91%
D&A For EBITDA	255.2	249.36	218.51	186.98	143.94	111.4
EBIT	2,319	2,224	2,012	1,928	1,377	1,191
EBIT Margin	9.65%	9.24%	8.91%	9.69%	8.99%	9.06%
Effective Tax Rate	24.89%	24.27%	22.41%	24.19%	25.95%	25.54%
Revenue as Reported	24,022	24,062	22,588	19,886	15,326	13,145

Source: S&P Global Market Intelligence. Standard template. Financial Sources.